Investigation of the effectiveness of the Russian single-component vaccine “Satellite Light” in Argentina showed a high result: a booster injection of the drug gives a strong immune response. This is stated in the official twitter -Aktnika “Satellite V”, which leads the Russian direct investment fund (RPI ).
These results showed the world’s first combined research in Argentina, conducted with the support of the RDII. In addition, a strong immune response gives a booster vaccination with the drug of Moderna.
Previously, the National Research Center of Epidemiology and Microbiology named after N. F. Gamaley reported that the effectiveness of the Satellite Light single-component vaccine against the Delta strain is the most common version of Coronavirus in Russia – is 70 percent.
In addition, the Satellite Light showed the effectiveness of more than 80 percent among the elderly in Argentina.